323 related articles for article (PubMed ID: 22494592)
21. Late toxicity and patient self-assessment of breast appearance/satisfaction on RTOG 0319: a phase 2 trial of 3-dimensional conformal radiation therapy-accelerated partial breast irradiation following lumpectomy for stages I and II breast cancer.
Chafe S; Moughan J; McCormick B; Wong J; Pass H; Rabinovitch R; Arthur DW; Petersen I; White J; Vicini FA
Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):854-9. PubMed ID: 23726000
[TBL] [Abstract][Full Text] [Related]
22. Five-year results of whole breast intensity modulated radiation therapy for the treatment of early stage breast cancer: the Fox Chase Cancer Center experience.
Keller LM; Sopka DM; Li T; Klayton T; Li J; Anderson PR; Bleicher RJ; Sigurdson ER; Freedman GM
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):881-7. PubMed ID: 22909414
[TBL] [Abstract][Full Text] [Related]
23. Hypofractionated Breast Radiation: Shorter Scheme, Lower Toxicity.
Linares I; Tovar MI; Zurita M; Guerrero R; Expósito M; Del Moral R
Clin Breast Cancer; 2016 Aug; 16(4):262-8. PubMed ID: 26454613
[TBL] [Abstract][Full Text] [Related]
24. Risk factors of developing long-lasting breast pain after breast cancer radiotherapy.
Lundstedt D; Gustafsson M; Steineck G; Malmström P; Alsadius D; Sundberg A; Wilderäng U; Holmberg E; Johansson KA; Karlsson P
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):71-8. PubMed ID: 22079722
[TBL] [Abstract][Full Text] [Related]
25. Three-dimensional conformal simultaneously integrated boost technique for breast-conserving radiotherapy.
van der Laan HP; Dolsma WV; Maduro JH; Korevaar EW; Hollander M; Langendijk JA
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(4):1018-23. PubMed ID: 17379440
[TBL] [Abstract][Full Text] [Related]
26. Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical study.
Benitez PR; Streeter O; Vicini F; Mehta V; Quiet C; Kuske R; Hayes MK; Arthur D; Kuerer H; Freedman G; Keisch M; Dipetrillo T; Khan D; Hudes R
Am J Surg; 2006 Oct; 192(4):427-33. PubMed ID: 16978943
[TBL] [Abstract][Full Text] [Related]
27. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.
Vargas C; Kestin L; Go N; Krauss D; Chen P; Goldstein N; Martinez A; Vicini FA
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1514-21. PubMed ID: 16005576
[TBL] [Abstract][Full Text] [Related]
28. Predictive factors for late normal tissue complications following radiotherapy for breast cancer.
Lilla C; Ambrosone CB; Kropp S; Helmbold I; Schmezer P; von Fournier D; Haase W; Sautter-Bihl ML; Wenz F; Chang-Claude J
Breast Cancer Res Treat; 2007 Nov; 106(1):143-50. PubMed ID: 17221151
[TBL] [Abstract][Full Text] [Related]
29. Effect of adjuvant systemic treatment on cosmetic outcome and late normal-tissue reactions after breast conservation.
Johansen J; Overgaard J; Overgaard M
Acta Oncol; 2007; 46(4):525-33. PubMed ID: 17497320
[TBL] [Abstract][Full Text] [Related]
30. Four-week course of radiation for breast cancer using hypofractionated intensity modulated radiation therapy with an incorporated boost.
Freedman GM; Anderson PR; Goldstein LJ; Ma CM; Li J; Swaby RF; Litwin S; Watkins-Bruner D; Sigurdson ER; Morrow M
Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):347-53. PubMed ID: 17379430
[TBL] [Abstract][Full Text] [Related]
31. Late radiation side effects, cosmetic outcomes and pain in breast cancer patients after breast-conserving surgery and three-dimensional conformal radiotherapy : Risk-modifying factors.
Hille-Betz U; Vaske B; Bremer M; Soergel P; Kundu S; Klapdor R; Hillemanns P; Henkenberens C
Strahlenther Onkol; 2016 Jan; 192(1):8-16. PubMed ID: 26416291
[TBL] [Abstract][Full Text] [Related]
32. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
33. DEGRO practical guidelines for radiotherapy of breast cancer I: breast-conserving therapy.
Sautter-Bihl ML; Budach W; Dunst J; Feyer P; Haase W; Harms W; Sedlmayer F; Souchon R; Wenz F; Sauer R; ;
Strahlenther Onkol; 2007 Dec; 183(12):661-6. PubMed ID: 18040609
[TBL] [Abstract][Full Text] [Related]
34. Five-year outcomes, cosmesis, and toxicity with 3-dimensional conformal external beam radiation therapy to deliver accelerated partial breast irradiation.
Rodríguez N; Sanz X; Dengra J; Foro P; Membrive I; Reig A; Quera J; Fernández-Velilla E; Pera Ó; Lio J; Lozano J; Algara M
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1051-7. PubMed ID: 24161420
[TBL] [Abstract][Full Text] [Related]
35. Role of radiotherapy boost in women with ductal carcinoma in situ: a single-center experience in a series of 389 patients.
Meattini I; Livi L; Franceschini D; Saieva C; Meacci F; Marrazzo L; Bendinelli B; Scotti V; De Luca Cardillo C; Nori J; Sanchez L; Orzalesi L; Bonomo P; Greto D; Bucciolini M; Bianchi S; Biti G
Eur J Surg Oncol; 2013 Jun; 39(6):613-8. PubMed ID: 23523088
[TBL] [Abstract][Full Text] [Related]
36. Prone whole-breast irradiation using three-dimensional conformal radiotherapy in women undergoing breast conservation for early disease yields high rates of excellent to good cosmetic outcomes in patients with large and/or pendulous breasts.
Bergom C; Kelly T; Morrow N; Wilson JF; Walker A; Xiang Q; Ahn KW; White J
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):821-8. PubMed ID: 22208973
[TBL] [Abstract][Full Text] [Related]
37. Late effects and cosmetic results of simultaneous integrated boost versus sequential boost after conventional irradiation in breast-conserving therapy; out come of 7 months follow-up.
Raiyawa T; Lertbutsayanukul C; Rojpornpradit P
J Med Assoc Thai; 2009 Mar; 92(3):390-7. PubMed ID: 19301734
[TBL] [Abstract][Full Text] [Related]
38. Accelerated partial breast irradiation using 3D conformal radiotherapy: toxicity and cosmetic outcome.
Gatti M; Ponzone R; Bresciani S; Panaia R; Kubatzki F; Maggiorotto F; Di Virgilio MR; Salatino A; Baiotto B; Montemurro F; Stasi M; Gabriele P
Breast; 2013 Dec; 22(6):1136-41. PubMed ID: 23958374
[TBL] [Abstract][Full Text] [Related]
39. Intraoperative radiotherapy (IORT) as a boost in patients with early-stage breast cancer -- acute toxicity.
Kraus-Tiefenbacher U; Bauer L; Kehrer T; Hermann B; Melchert F; Wenz F
Onkologie; 2006 Mar; 29(3):77-82. PubMed ID: 16514267
[TBL] [Abstract][Full Text] [Related]
40. Radiation-induced fibrosis in the boost area after three-dimensional conformal radiotherapy with a simultaneous integrated boost technique for early-stage breast cancer: A multivariable prediction model.
Hammer C; Maduro JH; Bantema-Joppe EJ; van der Schaaf A; van der Laan HP; Langendijk JA; Crijns AP
Radiother Oncol; 2017 Jan; 122(1):45-49. PubMed ID: 27793444
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
